Theratechnologies Inc. (THTX)

Theratechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is December - November.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 26, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Market Capitalization	147	56	78	206	313	178
Market Cap Growth	168.50%	-28.42%	-62.16%	-34.17%	75.91%	-24.35%
Enterprise Value	181	74	113	235	318	206
Last Close Price	3.39	1.21	1.58	8.52	13.20	9.20
PS Ratio	1.75	0.65	0.95	2.57	4.48	2.69
PB Ratio	-	-2.21	-3.73	-9.12	17.61	55.16
P/FCF Ratio	20.98	23.45	-	-	-	-
P/OCF Ratio	20.95	23.45	-	-	-	-
EV/Sales Ratio	2.14	0.86	1.39	2.93	4.55	3.12
EV/EBITDA Ratio	20.66	6.99	-	-	-	-
EV/EBIT Ratio	25.36	9.06	-	-	-	-
EV/FCF Ratio	25.72	31.13	-	-	-	-
Debt / Equity Ratio	-1.56	-1.80	-2.82	-2.96	3.20	17.18
Debt / EBITDA Ratio	4.81	4.17	-	-	-	-
Debt / FCF Ratio	6.21	19.17	-	-	-	-
Asset Turnover	1.39	1.31	0.96	0.75	0.64	0.61
Inventory Turnover	2.86	3.60	1.53	0.98	0.68	0.96
Quick Ratio	0.54	0.72	1.15	0.41	1.21	0.82
Current Ratio	0.84	1.19	1.34	0.64	2.04	1.55
Return on Equity (ROE)	-	-	-	-	-302.37%	-161.57%
Return on Assets (ROA)	7.33%	7.79%	-6.33%	-23.48%	-14.38%	-10.31%
Return on Capital (ROIC)	17.18%	17.49%	-13.17%	-42.05%	-23.70%	-16.73%
Return on Capital Employed (ROCE)	58.90%	49.60%	-	-	-	-
Earnings Yield	-6.21%	-14.89%	-30.74%	-22.94%	-10.14%	-12.75%
FCF Yield	4.77%	4.26%	-7.69%	-7.61%	-5.63%	-7.64%
Buyback Yield / Dilution	-26.85%	-87.46%	-10.58%	-3.14%	-19.95%	-0.08%

Updated Jul 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q